Company Overview of Laccure AB
Laccure AB, a pharmaceutical company, develops products for the treatment of bacterial vaginosis (BV). Its products are based on a proprietary substance that releases lactic acid to establish a physiological low ph in the vagina in BV patients. The company is based in Helsingborg, Sweden.
Helsingborg, 252 20
46 7 05 23 01 01
46 42 38 74 01
Key Executives for Laccure AB
Laccure AB Key Developments
Similar Private Companies By Industry
|AcuCort AB (publ)||Europe|
|Aditech Pharma AB||Europe|
|Apotek Produktion & Laboratorier AB||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Laccure AB, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.